A case of Vogt-Koyanagi-Harada-like uveitis secondary to dabrafenib/trametinib therapy for advanced melanoma
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
We report a case of ocular drug toxicity consistent with bilateral Vogt-Koyanagi-Harada (VKH) like disease in a patient with cutaneous melanoma treated with Dabrafenib/Trametinib therapy. A 53-year-old man with a history of metastatic cutaneous melanoma, treated with Dabrafenib/Trametinib, developed a severe acute panuveitis with granulomatous anterior uveitis and multiple serous retinal detachments. The ocular inflammatory reaction was classified as a bilateral Vogt-Koyanagi-Harada disease. Intraocular inflammation resolved after discontinuation of chemotherapeutic agents and aggressive topical and systemic corticosteroid therapy. The present case outlines the importance of recognizing VKH-like syndrome as a possible consequence of therapy with dabrafenib and trametinib.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“severe bilateral panuveitis during a combined Dabrafenib + Trametinib treatment has been separately reported on multiple occasions [ 194 , 226 ]”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [226]
Citations
Cites
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720 · cited 2×
“NP110 European Journal of Ophthalmology 32(1)”
Clinical and Morphologic Characteristics of MEK Inhibitor–Associated Retinopathy
Francis, J. H., Habib, L. A., Abramson, D. H., Yannuzzi, L. A., Heinemann, M., Gounder, M. M., Grisham, R. N., Postow, M. A., Shoushtari, A. N., Chi, P., et al. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.05.038 · Cited by 141
Ocular Adverse Events Associated with Mek Inhibitors
Méndez-Martínez, S., Calvo, P., Ruiz-Moreno, O., Pardiñas Barón, N., Leciñena Bueno, J., Gil Ruiz, M. D. R., & Pablo, L. (2019) · Retina · doi:10.1097/iae.0000000000002451 · Cited by 117
Ocular Toxicity in BRAF Mutant Cutaneous Melanoma Patients Treated With Vemurafenib
Choe, C. H., McArthur, G. A., Caro, I., Kempen, J. H., & Amaravadi, R. K. (2014) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2014.07.003 · Cited by 113
The Bacillary Detachment in Posterior Segment Ocular Diseases
Cicinelli, M. V., Giuffré, C., Marchese, A., Jampol, L. M., Introini, U., Miserocchi, E., Bandello, F. M., & Modorati, G. M. (2019) · Ophthalmology Retina · doi:10.1016/j.oret.2019.12.003 · Cited by 71
Self-citationLim, J. W. Y., Lomax, A. J., McNeil, C. M., & Harrisberg, B. P. (2016) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2016.1246666 · Cited by 34
Uveitis, Poliosis, Hypomelanosis, and Alopecia in a Patient With Malignant Melanoma
Sober, A. J. (1978) · Archives of Dermatology · doi:10.1001/archderm.1978.01640150075022 · Cited by 29
Diamantopoulos, P. T., Stoungioti, S., Anastasopoulou, A. N., Papaxoinis, G., & Gogas, H. J. (2018) · Melanoma Research · doi:10.1097/cmr.0000000000000505 · Cited by 29
Vogt–Koyanagi–Harada syndrome associated with cutaneous malignant melanoma: an 11-year follow-up
Aisenbrey, S., Lüke, C., Ayertey, H. D., Grisanti, S., Perniok, A., & Brunner, R. A. (2003) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-003-0787-5 · Cited by 23
Research works printed but not linked: 2
- Lim J, 2018, Ocul Immunol Inflamm, 26, 628
- Stein ZL., 1980, Am J Hosp Pharm, 37
Cited by
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
Ocular Toxicity of Targeted Anticancer Agents
Fortes, B. H., Tailor, P. D., & Dalvin, L. A. (2021) · Drugs · doi:10.1007/s40265-021-01507-z · Cited by 64
“[21] Vogt-Koyanagi-Harada-like syndrome (combined with trametinib): 2 cases IV methylprednisolone, oral prednisone taper, and topical corticosteroids Y”
BackgroundCancer Immunotherapy and Uveitis: Balancing Anti-Tumor Immunity and Ocular Autoimmunity
Rali, A. S., Ye, H., & Yeh, S. (2022) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000434 · Cited by 19
Pharmacologically induced uveitis
Elsayed, M. E. A. A., & Kozak, I. (2021) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2021.01.003 · Cited by 18
BRAF inhibition and the spectrum of granulomatous reactions
Pham, J. P., Star, P., Phan, K. H., Loh, Y., Joshua, A. M., & Smith, A. D. (2021) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2021.10.030 · Cited by 15
Metadata
- Authors
- Brambati, M., Giuffrè, C., Marchese, A., Bandello, F., Modorati, G. M., & Miserocchi, E.
- Affiliations
- Vita-Salute San Raffaele University (IT)
- Department of Ophthalmology, San Raffaele Scientific Institute, University Vita-Salute, Milan, Italy
- Corresponding author
- Miserocchi, Elisabetta
- ORCID
- Venue
- European Journal of Ophthalmology
- Publisher
- SAGE Publications
- Published
- 2020-10-01
- Volume
- 32
- Issue
- 1
- Pages
- NP109-NP113
- ISSN
- 1120-6721 (ISSN-L)
- 1724-6016
- OpenAlex
- W3091549040
- Cited by
- 26
- References
- 9
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 4 · 2023: 4 · 2022: 7 · 2021: 3
- FWCI
- 2.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- European Journal of Ophthalmology (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Ophthalmology › Drug-Induced Ocular Toxicity
- Health Sciences › Medicine › Ophthalmology › Ocular Oncology and Treatments
- Keywords
- uveitis, dabrafenib, trametinib, cutaneous melanoma, drug-induced ocular toxicity, panuveitis, granulomatous anterior uveitis, serous retinal detachment, corticosteroid therapy
- MeSH terms
- Humans, Imidazoles, Male, Melanoma, Middle Aged, Oximes, Pyridones, Pyrimidinones, Skin Neoplasms, Uveitis, Uveomeningoencephalitic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A case of Vogt-Koyanagi-Harada-like uveitis secondary to dabrafenib/trametinib therapy for advanced melanoma. https://app.cochat.ai/papers/10.1177/1120672120962044
- The paper
- Brambati, M., Giuffrè, C., Marchese, A., Bandello, F., Modorati, G. M., & Miserocchi, E. (2022). A case of Vogt-Koyanagi-Harada-like uveitis secondary to dabrafenib/trametinib therapy for advanced melanoma. European Journal of Ophthalmology. https://doi.org/10.1177/1120672120962044
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.